Earnings History Data for Aldeyra Therapeutics (ALDX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Aldeyra Therapeutics
Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
28-02-2025 | AH | ALDX | Aldeyra Therapeutics | 392.00 | -0.27 | -0.25 | 0.00 | 6.09 | 0.98 (19.18%) |
5.23 | 0.12 (2.35%) |
2.71 - 6.92 | 1,333,128 | 550,000 | 4,452 | |||
|
||||||||||||||||||
07-03-2024 | AH | ALDX | Aldeyra Therapeutics | 231.00 | -0.08 | -0.21 | 0.00 | 3.61 | -0.24 (-6.21%) |
3.78 | -0.07 (-1.76%) |
1.42 - 11.97 | 732,452 | 520,000 | 5,084 | |||
09-03-2023 | PM | 7:00 AM ET (Mar 9) |
ALDX | Aldeyra Therapeutics, Inc. | 406.41 | -0.22 | -0.34 | -0.27 | Aldeyra Therapeutics GAAP EPS of -$1.06 beats by $0.10 [3/9/2023 7:03 AM] |
7.89 | 0.52 (7.06%) |
7.75 | 0.38 (5.12%) |
2.36 - 7.99 | 818,341 | 470,000 | 1,494 | |
10-11-2022 | PM | 7:00 AM ET (Nov 10) |
ALDX | Aldeyra Therapeutics, Inc. | 316.11 | -0.25 | -0.34 | -0.27 | Aldeyra Therapeutics GAAP EPS of -$0.25 beats by $0.10 [11/10/2022 7:02 AM] |
5.53 | 0.35 (6.76%) |
5.10 | -0.08 (-1.54%) |
2.36 - 9.35 | 624,001 | 260,000 | 959 | |
05-08-2022 | PM | 7:00 AM ET (Aug 5) |
ALDX | Aldeyra Therapeutics, Inc. | 304.33 | -0.30 | -0.32 | -0.28 | Aldeyra Therapeutics GAAP EPS of -$0.30 beats by $0.02 [8/5/2022 7:05 AM] |
6.92 | 0.68 (10.90%) |
6.92 | 0.0 (0.00%) |
2.35 - 10.19 | 2,065,763 | 790,000 | 1,437 | |
|
||||||||||||||||||
05-05-2022 | PM | 7:00 AM ET (May 5) |
ALDX | Aldeyra Therapeutics, Inc. | 177.82 | -0.29 | -0.31 | -0.25 | Aldeyra Therapeutics GAAP EPS of -$0.29 beats by $0.04 [5/5/2022 7:19 AM] |
2.79 | -0.14 (-4.95%) |
2.95 | 0.02 (0.68%) |
2.71 - 13.18 | 598,776 | 870,000 | 177,776 | |
|
||||||||||||||||||
17-03-2022 | PM | 7:00 AM ET (Mar 17) |
ALDX | Aldeyra Therapeutics, Inc. | 223.65 | -0.27 | -0.31 | -0.35 | Aldeyra Therapeutics GAAP EPS of -$1.07 beats by $0.02 [3/17/2022 7:01 AM] |
4.87 | 0.69 (16.51%) |
4.51 | 0.33 (7.89%) |
3.00 - 15.95 | 1,070,275 | 1,266,838 | 12,378 | |
28-10-2021 | PM | 7:00 AM ET (Oct 28) |
ALDX | Aldeyra Therapeutics, Inc. | 463.49 | -0.27 | -0.29 | -0.23 | Aldeyra Therapeutics EPS misses by $0.01 [10/28/2021 7:10 AM] |
9.00 | 0.76 (9.22%) |
8.21 | -0.03 (-0.36%) |
6.21 - 15.95 | 749,617 | 500,000 | 122 | |
05-08-2021 | PM | 7:00 AM ET (Aug 5) |
ALDX | Aldeyra Therapeutics, Inc. | 515.80 | -0.28 | -0.27 | -0.25 | Aldeyra Therapeutics EPS misses by $0.03 [8/5/2021 7:08 AM] |
9.57 | 0.73 (8.26%) |
9.00 | 0.16 (1.81%) |
5.53 - 15.95 | 496,459 | 490,000 | 311 | |
|
||||||||||||||||||
06-05-2021 | PM | 7:00 AM ET (May 6) |
ALDX | Aldeyra Therapeutics, Inc. | 570.05 | -0.25 | -0.29 | -0.34 | Aldeyra Therapeutics EPS beats by $0.01 [5/6/2021 7:12 AM] |
12.05 | 0.08 (0.67%) |
12.05 | 0.0 (0.00%) |
2.73 - 15.95 | 1,383,844 | 10,830,000 | 4,829 | |
11-03-2021 | PM | 7:00 AM ET (Mar 11) |
ALDX | Aldeyra Therapeutics, Inc. | 486.76 | -0.35 | -0.27 | -0.47 | Aldeyra Therapeutics EPS misses by $0.02 [3/11/2021 7:09 AM] |
12.07 | -0.01 (-0.08%) |
11.50 | -0.58 (-4.80%) |
1.48 - 14.62 | 558,145 | 617,868 | 4,644 | |
|
||||||||||||||||||
05-11-2020 | PM | 7:00 AM ET (Nov 5) |
ALDX | Aldeyra Therapeutics, Inc. | 256.91 | -0.23 | -0.28 | -0.69 | Aldeyra Therapeutics EPS beats by $0.04 [11/5/2020 7:20 AM] |
6.93 | 0.14 (2.06%) |
6.95 | 0.02 (0.29%) |
1.48 - 8.70 | 572,698 | 493,969 | 15,799 | |
|
||||||||||||||||||
06-08-2020 | PM | 7:00 AM ET (Aug 6) |
ALDX | Aldeyra Therapeutics, Inc. | 225.13 | -0.25 | -0.34 | -0.49 | Aldeyra Therapeutics EPS beats by $0.09 [8/6/2020 7:34 AM] |
6.66 | -0.80 (-10.72%) |
6.98 | -0.48 (-6.43%) |
1.48 - 8.05 | 911,295 | 1,167,016 | 85,046 | |
|